Latest Announcement: Posters and podium sessions have been updated on the scientific programme page.                    Latest Announcement: Posters and podium sessions have been updated on the scientific programme page.                        Latest Announcement: Posters and podium sessions have been updated on the scientific programme page.                       Latest Announcement: Posters and podium sessions have been updated on the scientific programme page.                       Latest Announcement: Posters and podium sessions have been updated on the scientific programme page. 
Scientific Programme
  • 12 December 2009 (Day 1)
  • 13 December 2009 (Day 2)
  • 14 December 2009 (Day 3)
  • 15 December 2009 (Day 4)
  • Posters
12 DECEMBER 2009, SATURDAY (DAY 1)
8.00 am Registration
9.30 am Opening Address
Theatre
10.00 am Keynote Lecture
Chairperson : P Ganesan ADAIKAN (Singapore)
 
Future of Sexual Medicine
John DEAN (United Kingdom)
President, International Society for Sexual Medicine
Theatre
10.30 am Coffee Break
11.30 am Plenary Session 1
Chairpersons: Akira TSUJIMURA (Japan); Man Kay LI (Singapore)

Future Medical Approaches to ED: A Case for Gene Therapy
Arnold MELMAN (USA)
Theatre
12.00 noon Plenary Session 2
Chairpersons: Ira SHARLIP (USA); Carolyn EARLE (Australia)

Therapeutic Uses of PDE5 Inhibitors – What is the Future?
Akira TSUJIMURA (Japan)
12.30 pm Plenary Session 3
Chairpersons: Khaled DABEES (Egypt); Nam Cheol PARK (Korea)

Radical Prostatectomy – Evidence-based Approaches for Sexual Rehabilitation
Han Sun CHIANG (Taiwan)
1.00 pm Lunch & Sponsored Symposium by Bayer (South East Asia) Pte Ltd
2.30 pm ISSM Symposium: New Concepts in Sexual Medicine
Chairperson: John DEAN (United Kingdom)
Theatre
2.30 pm
Genital Cancer, Male Identity and Couples’ Sexual Function
Luca INCROCCI (The Netherlands)
 
2.50 pm
Metabolic Syndrome and Sexual Dysfunction
Edgardo BECHER (Argentina)
 
3.10 pm
What’s New in Premature Ejaculation
Wayne HELLSTROM (USA)
 
3.30 pm
Male Circumcision and HIV Prevention
Ira SHARLIP (USA)
 
3.50 pm
Update on Women’s Sexual Health
John DEAN (United Kingdom)
 
4.00 pm Coffee Break
Concurrent Session    
4.30 pm RAS – Special Lectures
Chairpersons: Luca INCROCCI (The Netherlands); Han Sun CHIANG (Taiwan)
Theatre
4.30 pm
AGSSM Presentation
Khaled DABEES (Egypt)
 
5.00 pm
SMSNA Presentation
Ajay NEHRA (USA)
 
4.30 pm Symposium 2: Male Pelvic Surgery and Sexual Function
Chairpersons: Jong Kwan PARK (KOREA); Simon CHONG (Singapore)
Room 203
4.30 pm
ED and Prostatectomy
Masato FUJISAWA (Japan)
 
4.50 pm Surgical Treatment for Erectile Dysfunction
Koichi NAGAO (Japan)
 
5.10 pm Complications of Penile Implantations
Jong Kwan PARK (Korea)
 
5.30 pm Penile Augmentation Using Filler, Injectable Hyaluronic Acid Gel
Du Geon MOON (Korea)
5.50 pm 3-flaps of Penile Augmentation
Khaled DABEES (Egypt)
6.00 pm End of Session

 

 

13 DECEMBER 2009, SUNDAY (DAY 2)
8.30 am Highlights
Theatre
8.30 am
Highlights of Day 2 – Plenary Sessions
George LEE (Malaysia)
 
8.45 am
Highlights of Day 2 – Symposia Sessions
Wah Yun LOW (Malaysia)
 
9.00 am
Plenary 4
Chairpersons: Kuang Kuo CHEN (Taiwan); Narayana REDDY (India)

Physiological Basis of Human Arousal Responses
David ROWLAND (USA)
Theatre
9.30 am
Plenary 5
Chairpersons: Tai Young AHN (Korea); Yasusuke KIMOTO (Japan)

Tissue Engineering Surgery for Small Penis Syndrome
Zhong Cheng XIN (China)
Theatre
10.00 am Coffee Break
Concurrent Session
10.30 am Debate 1
Moderators: Ajay NEHRA (USA); George LEE (Malaysia)

Premature Ejaculation – Drugs vs Behavioural Therapy
Drugs: Chris MCMAHON (Australia)
Behavioural: David ROWLAND (USA)
Theatre
10.30 am      Debate 2
Moderators: Hui Meng TAN (Malaysia); Antonio Martin MORALES (Spain)

Metabolic Syndrome and ED: Can Changing Lifestyle Change ED?
Yes: Luiz Otavio TORRES (Brazil)
No: Wayne HELLSTROM (USA)

 
Room 203
Concurrent Session
11.30 am   Podium 1: Epidemiology and Risk Factors
Chairpersons: Kew Kim CHEW (Australia); Baharudin B SAID (Singapore)
Theatre
11.30 am
O1.1
How ED Couples Face Pleasant and Unpleasant Sexual Experiences
Y CHEN; CC LU; BP JIANN (Taiwan)
 
11.40 am

O1.2
The Frequency of Intercourse in Asia Pacific Countries with Different
Economic, Cultural and Religious Backgrounds and its Changes with
Advancing Age
G LEE (Malaysia)

 
11.50 am

O1.3
Erectile Dysfunction among South Asian and European Men with and without Diabetes Living in the UK
LS MALAVIGE(UK) ; D SENERVIRATNE-EPA (UK); PN WIJESEKARA(Sri Lanka); SD JAYARATNE (Sri Lanka); S SIVAYOGAN (Sri Lanka); S KATHRIARACHCHI (Sri Lanka); J BANCROFT (USA); JC LEVY (UK)

 
12.00 noon
O1.4
Whether Obesity Correlated with Sexual Function in Young Adult Males
CW TSAO; ME; ST WU; GH SUN; DS YU; PL FAN; HI CHEN; SY CHANG; TL CHA (Taiwan)
 
12.10 pm
O1.5
Erectile Dysfunction and Peripheral Neuropathy in Patients with Diabetes Mellitus
T AMANO; T IMAO; K TAKEMAE; Y OHTA; S SSAKAI; H OHTA (Japan)
 
12.20 pm
O1.6
Effects of Cigarette-smoke Exposure on Erectile Function and Hormone Level in Male Rats
MG PARK; KW KO; JH BAE; DS LEE; DG MOON; JJ KIM (Korea)
 
12.30 pm
O1.7
Does Smoking Cessation Reduce Prevalent Erectile Dysfunction in Cigarette Smokers?
KK CHEW (Australia)
 
12.40 pm
O1.8
Does Male Erectile Dysfunction Predict Future Atherosclerotic Cardiovascular Events?
KK CHEW (Australia)
 
12.50 pm
O1.9
Effects OF Stroke on Sexual Functioning and Its Associated Factors in Malaysian Man
ABDUL AZIZ N; WY LOW; FREDDY ABDULLAH SJ (Malaysia)
 
11.30 am Podium 2: Basic Science
Chairpersons: Kuang Kuo CHEN (TAIWAN); Zhong Cheng XIN (China)
Room 203
11.30 am
O2.1
Functional Characterization of H2S-NO Bioavailability and Activity in Cavernosal Relaxation
RL LIAW (Singapore); SM JAMEELAH (Singapore); B SRILATHA (Singapore); PG ADAIKAN (Singapore); PK MOORE (United Kingdom)
 
11:40 am
O2.2
H2S-NO Cross-talk and Interaction in Erectile Function
P MUTHULAKSHMI (Singapore); RL LIAW (Singapore); B SRILATHA (Singapore); PG ADAIKAN (Singapore); PK MOORE (United Kingdom)
11.50 am
O2.3
Are Chloride Channel Blockers Effective in Restoring Diabetes-Induced Erectile Dysfunction in Rabbit?
LC LAU; PG ADAIKAN (Singapore)
12.00 noon
O2.4
Response of Corpus Cavernosum to Vasoactive Agent in the Hyperprolactinemic Rat
KK CHEN; WJS HUANG; LS CHANG (Taiwan)
12.10 pm
O2.5
Simultaneous Increase of Intracavernous and Seminal Vesical Pressures
KK CHEN; LS CHANG (Taiwan)
12.20 pm
O2.6
The Effect of Electrical Stimulation of Lesser Splanchnic Nerve on Bilateral Seminal Vesical Pressures in the Rat
KK CHEN; LS CHANG (Taiwan)
12.30 pm
O2.7
Icarisid II, a PDE5 Inhibitor from Epimedium Wanshanense, Increases Cellular cGMP by Enhancing NOS in Rat Cavernosum Smooth Muscle Cells
J ZHANG; XC QIN; T LIU; WR LI; WS CUI; YQ GONG; ZC XIN (China)
12.40 pm
O2.8
A Brief Overview of Recent Advances in Human Penile Anatomy and Erection Physiology
GL HSU (Taiwan)
12.50 pm
O2.9
Penile Veins are the Determining Contributor for Erection: The Hemodynamic Evidence from the Study in Defrosted Human Cadavers
GL HSU; CH HSIEH; YP HUANG; MH TSAI; KL CHEN; CH CHANG; HC WU (Taiwan)
1.00 pm       Sponsored Symposium by Johnson & Johnson Pte Ltd  
2.30 pm   Sponsored Symposium by Pfizer Pte Ltd  
3.30 pm Coffee Break
Concurrent Session
4.00 pm Symposium 3: Trends in the Pharmacotherapy of ED
Chairpersons: T R MURALI (India); Lewis LIEW (Singapore)  
 
Theatre
4.00 pm
PDE5Is: Present and Future
Koichi NAKAJIMA (Japan)
 
4.20 pm
Strategies in the Management of PDE5Is Non-responders
Ken MARUMO (Japan)
 
4.40 pm
Daily Dosing of PDE5Is in LUTS
Sae Woong KIM (Korea)
 
5.00 pm
Treatment Options Beyond PDE5Is
T R MURALI (India)
 
4.00 pm  Symposium 4: Female Sexual Function and Dysfunction
Chairpersons: Yap Seng CHONG (Singapore); Lang Chu LAU (Singapore)        
Room 203
4.00 pm
Physiologic Mechanism of Vaginal Lubrication
Kwangsung PARK (Korea)
 
4.15 pm

Updates in Female Sexual Dysfunction
Haruaki SASAKI (Japan)

 
4.30 pm
Menopausal Barriers to Sexual Satisfaction
Vesna DRAMUSIC (Singapore)
 
4.45 pm
Pelvic Floor Weakness and FSD
James LEE (Singapore)
 
Concurrent Session
5.00 pm    Podium 3 : Diagnosis and Management - Medical Treatment 
Chairpersons: Sae Chul KIM (Korea); Thomas I S Hwang (Taiwan)
Theatre
5.00 pm
O3.1
Clinical Features and Treatment Options for Chinese Patients with Severe
Primary Erectile Dysfunction
  ZC XIN; YC ZHU; JL ZHAO; YG WU; YM YUAN; WQ LIAN; J ZHANG; WS CUI; Z JIN (China)
 
5.10 pm

O3.2
The Effect of Daily Dosing of Tadalafil 5mg on Improvement of Insulin
Resistance and Endothelial Function in Patients with ED
SC KIM; SJ PARK (Korea)

 
5.20 pm
O3.3
Efficacy and Safety of Nasal Spray Containing Apomorphine Hydrochloride
and Phentolamine Mesylate in Treatment of Men with Erectile Dysfunction
DL ARUSTAMOY; FA AKILOV; S SHAVAKHABOV; BR RUSTAMOV; AA FOZILOY (Uzbekistan)
 
5.30 pm

O3.4
Statin is Effective in Restoring Diabetic Erectile Dysfunction When Combined
with Insulin Treatment
MC CHO; K PARK, SW KIM, JS PAICK (Korea)

 
5.45 pm

O3.5
Changes of Sexual Functions in BPH Patients Taking Dutasteride: 1 Year
Follow Up
SC KIM; BH CHI (Korea)

 
5.50 pm

O3.6
Sexuality and Management of Benign Prostatic Hyperplasia with Alfuzosin
TIS HWANG; PH CHIANG; MS LIN; CS CHEN; LM LEE
                                          (Taiwan)

 
5.00 pm  Podium 4 : Female Sexual Function & Dysfunction
Chairpersons:Bang Ping JIANN (TAIWAN); Shin-ichi HISASUE (Japan)
Room 203
5.00 pm

O4.1
Risk Factors for Female Sexual Dysfunction
BP JIANN (Taiwan)

 
5.10 pm

O4.2
Comparison of the Clitoral Intracavernous Pressure Change Induced
Between Intraclitoral Administration of YC-1 and Epimedium Brevicornum
Maxim Extract in the Rabbit
KK CHEN; LS CHANG (Taiwan)                 

 
5.20 pm
O4.3
The Impact of the Cohabitation with Females on the Recovery from the
Erectile Dysfunction Following Cavernous Nerve Injury in Rats
S HISASUE; K HASHIMOTO; M TAKEUCHI; Y KYODA; K KOBAYASHI;
H KITAMURA; S TAKAHASHI; N MASULMORI; T TSUKAMOTO (Japan)
 
5.30 pm

O4.4
Evaluation of Satisfaction Rate and Approach to Sexual Intercourse in 510
Women Referred to 4 Medical Centers (Jan - Dec 2007)
B KHANEDAN; H KAVARI (Iran)

 
5.40 pm

O4.5
Women’s Sexual Attractiveness: The Effect f Chemotherapy Treatment for
Breast Cancer
N YUSOFF; WY LOW; CH YIP (Malaysia)

 
5.50 pm

O4.6
Effect of Aqueous Glycyrrhiza Extract on Menopausal Symptoms
A FATEMEH (Iran)

6.00 pm     End of Session
14 DECEMBER 2009, MONDAY (DAY 3)
8.30 am Highlights 
Theatre
8.30 am 
Highlights of Day 3 – Plenary and Symposia Sessions
Sudhakar KRISHNAMURTI (India)
 
8.45 am
Highlights of Day 3 – Debate and Podium Sessions
S S VASAN (India)
 
9.00 am     Plenary 6
Chairpersons: Wayne HELLSTROM (USA); Je Jong KIM (Korea)

New Insights into Priapism
Ajay NEHRA (USA)
Theatre
9.30 am     Plenary 7
Chairpersons: Rosemary COATES (Australia); B SRILATHA (Singapore)

FSD Management: Past, Present and the Future
Annamaria GIRALDI (Denmark)
Theatre
10.00 am     Coffee Break
Concurrent Session
10.30 am     

Debate 3                         
Moderators: Edgardo BECHER (Argentina); Zhong Cheng XIN (China)
                                                        
Can ED be prevented after Surgical Treatment of Prostate Cancer?
Yes: Luca INCROCCI (the Netherlands)
No: S S Vasan (India)

Theatre
10.30 am       Debate 4      
Moderators: James WS LEE (Singapore); Anupriya AGARWAL (Singapore)

Is There a Role for Drugs in Hypoactive Sexual Desire Disorder?
Yes: Annamaria GIRALDI (Denmark)
No: Wah Yun LOW (Malaysia)
Room 203
Concurrent Session
11.30 am 

Podium 5 : Ejaculatory Dysfunctions 
Chairpersons: Chris MCMAHON (AUSTRALIA); Jong Kwan PARK (KOREA)       

Theatre
11.30 am
O5.1
Expressional Profile of Seminal Vesicle Genes in Men with and without Ejaculatory Dysfunction
MC TSAI; PY LIN; YM LIN; JSN LIN (Taiwan)
 
11.40 am
O5.2
Incidence of Lifelong and Acquired Premature Ejaculation in the Asia-Pacific Region
PG ADAIKAN (Singapore); CG MCMAHON (Australia); G LEE (Malaysia);
JK PARK (Korea)
 
11.50 am
O5.3
Prevalence of Premature Ejaculation and Erectile Dysfunction in the Asia- Pacific Region
JK PARK (Korea); PG ADAIKAN (Singapore); CG MCMAHON (Australia);
G LEE (Malaysia)
 
12.00 noon
O5.4
Premature Ejaculation - Prevalence and Attitudes in the Asia-Pacific Region
CG MCMAHON (Australia); JK PARK (Korea); PG ADAIKAN (Singapore);
G LEE (Malaysia)
                                        
 
12.10 pm

O5.5
Variation between Countries in the Asia-Pacific Region in the Prevalence of
Premature Ejaculation (PE)
G LEE (Malaysia); CG MCMAHON (Australia); JK PARK (Korea);
PG ADAIKAN (Singapore)

 
12.20 pm

O5.6
Premature Ejaculation among South Asian and Europid Men with and without
Diabetes Living in the UK
LS MALAVIGE (UK); D SENERVIRATNE-EPA (UK); PN WIJESEKARA (Sri Lanka);
SD JAYARATNE (Sri Lanka); S SIVAYOGAN (Sri Lanka); S KATHRIARACHCHI (Sri Lanka); J BANCROFT (Sri Lanka); JC LEVY(USA)

 
11.30 am       Podium 6: Aging Male, Hormones, and Lifestyle Factors
Chairpersons: Michael ZITZMANN (Germany); Min-gu PARK (Korea)
Room 203
11.30 am
O6.1
The Correlation between Serum Total Testosterone and AMS and IIEF
Questionnaires in Patients of Erectile Dysfunction with Testosterone
Deficiency Syndrome 
MG PARK; DS LEE; JH BAE; DG MOON; JJ KIM (Korea)
 
11.40 am
O6.2
Testosterone Treatment Enhances the Beneficial Effects of Lifestyle
Changes on Inflammation and Pro-Coagulatory Markers in Hypogonadal
Men
F SAAD (Germany); L GOOREN (The Netherlands); A HEUDELDER (Germany)
 
11:50 am
O6.3
Time Table Effects of Testosterone Therapy in Hypogonadal Men on
Psychosexual Variables
F SAAD; F JOCKENHOEVEL; T MINNEMANN; M SCHUBERT;
S
FREUDE; D HUEBLER; C SCHUMANN; A CHRISTOPH; M ERNST (Germany)
 
12.00 noon
O6.4
IPASS: Data from an Ongoing Study of the Tolerability and Effectiveness of
Injectable Testosterone Undecanoate for the Treatment of Male
Hypogonadism
M ZITZMANN; JU HANISCH; A MATTERN (Germany)
 
12.10 pm
O6.5
Intramuscular Testosterone Undecanoate for Substitution in Male
Hypogonadism – the Experience of 11 Years Elucidates Beneficial Effects on
General Health Risk Factors and Reveals a High Degree of Safety
M ZITZMANN; F SAAD (Germany)
 
12.20 pm
O6.6
Baseline Testosterone Levels or Age as Predictors of Favourable Effects of
Normalizing Testosterone in Men with the Metabolic Syndrome
F SAAD; A HAIDER; A YASSIN (Germany)
 
12.30 pm
O6.7
Validation of an Arabic ADAM Questionnaire for Androgen Deficiency
Screening in the Arab Community
DM RAHAB; MA ARAFA (Kingdom of Saudi Arabia)
 
12.40 pm
O6.8
Linguistic Validation of Sexual Excitation Scale and Sexual Inhibition Scale
LS MALAVIGE (UK); PN WIJESEKARA (Sri Lanka); SD JAYARATNE (Sri  Lanka);
S SIVAYOGAN (Sri Lanka); S KATHRIARACHCHI (Sri Lanka); J BANCROFT (Sri Lanka); JC LEVY (USA)
 
12.50 pm
O6.9
The Effectiveness of Clomiphene Citrate Therapy for Male Infertility
T TAI; K NAGAO; K NAKAJIMA; T ISHIWATARI; Y OKA; S KANBE;
M NAGATA; F YAMABE; K TAKASUGI; S KAMIMURA; T SUYAMA; H KOBAYASHI;
K SUZUKI; N TANAKA; H HARA; K MIURA; N ISHII; M FUJIME
(Japan)
 
1.00 pm  Sponsored Symposium by Eli Lilly (Malaysia) Sdn Bhd                      
Theatre
Concurrent Session
2.30 pm Symposium 5: Primary Evaluations in Male Sexual Dysfunction  
Chairpersons: Bang Ping JIANN (Taiwan); Ng Kok KIT (Singapore)  
Room 203
2.30 pm
Advances in CNS Pharmacology for Sexual Dysfunction
Kuang Kuo CHEN (Taiwan)
 
2.50 pm
Sexual Function of Male Victims of Drug Abuse
Bang Ping JIANN (Taiwan)    
 
3.10 pm
Seminal Parameters and Sexual Function
T KAMARAJ (India)
 
3.30 pm
Ion Channels in Corporal Smooth Muscle: Clinical Implications
Sung Won LEE (Korea)
 
2.30 pm Symposium 6: Aging Male, Testosterone and LOH
Chairpersons: Kew Kim CHEW (Australia); Peter H C LIM (Singapore)
Room 203
2.30 pm
Prevalence of Sexual Disorders with Aging in Males
Kew Kim CHEW (Australia)
 
2.50 pm
Treatment of Testosterone Deficiency Syndrome
Je Jong KIM (Korea)
 
3.10 pm
Role of Cox7a2 on Testosterone Biosynthesis in Later Onset Hypogonadism (LOH)
Zhong Cheng XIN (China)
 
3.30 pm
LOH and TRT: Beneficial Effects and Safety Concerns
Arif ADIMOELJA (Indonesia)
 
4.00 pm  Coffee Break
Concurrent Session
4.30 pm    Podium 7 : Surgical Treatment, ED, LUTS, Peyronie’s Disease, Priapism
Chairpersons: Dong Suk KIM (Korea); Yuzo NAKANO (Japan)
Theatre
4.30 pm
O7.1
Clinical Experience of a Refined Penile Venous Stripping Surgery Procedure
for Patients with Erectile Dysfunction: Is It a Viable Option?
GL HSU; HS CHEN; CH HSIEH; WY LEE; KL CHEN; CH CHANG (Taiwan)
 
4.40 pm
O7.2
A Physiological Approach to a Penile Venous Stripping Surgical Procedure
for Patients with Erectile Dysfunction
GL HSU; CH HSIEH; YP HUANG; KL CHEN; CH CHANG (Taiwan)
 
4.50 pm
O7.3
Salvaging Penile Venous Stripping Surgery
GL HSU; HS CHEN; CH HSIEH; WL LEE; KL CHEN; CH CHANG (Taiwan)
 
5.00 pm
O7.4
Long-term Reliability of AMS 700CX/CXM Inflatable Penile Prosthesis
DS KIM; KM YANG; HM CHOI; HJ CHUNG; HK CHOI (Korea)
 
5.10 pm
O7.5
The Effect of BPH-related Variables on Health-related Quality of Life of
Elderly Male Patients before Prostatectomy in Taiwan
TF TSAI; LC CHANG; HS CHIANG; TIS HWANG (Taiwan)
 
5.20 pm

O7.6
Sexual Function Following Laparoscopic Radical Prostatectomy
Y NAKANO; H MIYAKE; K TANAKA; A TAKENAKA; M FUJISAWA
(Japan)

 
5.30 pm
O7.7
Patients with Male Sexual Dysfunction also Suffer From Male Lower Urinary
Tract Symptoms (LUTS)
T AMANO; T IMAO; K TAKEMAE (Japan)
 
5.40 pm
O7.8
Does Testosterone Deficiency Exaggerate the Clinical Symptoms of
Peyronie's Disease?
HJ PARK; JH AHN; NC PARK (Korea)
 
5.50 pm
O7.9
Corpus Cavernosum-Corpus Spongiosum Shunt Plus Intracavernous
Tunneling for Prolonged Ischemic Priapism
WQ LIAN; ZC XIN; YM YUAN; YC ZHU; JL ZHAO; YG WU; WS CUI; Z JIN (China)
 
4.30 pm   Podium 8 : Miscellaneous
Chairpersons: Hyung Ki CHOI (Korea); AWC YIP (Hong Kong)
Room 203
4.30 pm

O8.1
Erection Hardness is Associated with Sexual Satisfaction and Overall
Satisfaction with Life in the Asia-Pacific Region: Results From the Sexual
Health and Overall Wellness Study
AWC YIP (Hong Kong); JP PAICK (Korea); BP JIANN (Taiwan);
R KING (Australia); ML ONG (USA)

 
4.40 pm
O8.2
Treatment of Erectile Dysfunction with Sildenafil Citrate in Elderly
Parkinson’s Disease
MT PRANATA (Indonesia)
 
4.50 pm
O8.3
Comparison of Voiding Parameters According to the Classification of SS-
Penogram in Patients Combined with ED and LUTS
HM CHOI; HK CHOI; BH CHUNG; CE KIM (Korea)
 
5.00 pm

O8.4
Masculinity Traits and Gender Role Identity: Results from the Subang
Longitudinal Male Aging Study
WY LOW (Malaysia)

 
5.10 pm
O8.5
The Moscow Study: A Randomized, Placebo-Controlled, Double-Blind Trial
of Parenteral Testosterone Undecanoate on the Metabolic Syndrome and
Inflammation Markers
S Kalinchenko (Russia); Y TISHOVA (Russia); G MSKHALAYA (Russia);
E GILTAY(The Netherlands); L GOOREN (The Netherlands);  F SAAD (Germany)
 
5.20 pm
O8.6
Condom Use and Perceived HIV Infection among Geriatrics Aged 65-102
Years in Nigeria
KO ODOR; NC IGWE (Nigeria)
 
5.30 pm

O8.7
Sexual Health Education by Urban Indian Parents
NS RANE; J DCUNHA; K RANE
(India)

 
5.40 pm
O8.8
Sex Counseling and Therapy
S DESHPANDE (India )
 
5.50 pm

O8.9
Follow-up of Adolescent Reproductive and Sexual Health Program in India
S GUMASTE (India)

 
6.00 pm

O8.10
Knowledge, Attitude and Practice (KAP) of Pathobiology Laboratory Staff
about AIDS in Sari, Iran
A FATEMEH (Iran)

 
6.00 pm   End of Session 
7.00 pm   Congress Banquet 
15 DECEMBER 2009, TUESDAY (DAY 4)
8.00 am  Highlights
Room 203
  8.00 am
Highlights of Day 4 – Plenary & Symposia Sessions
James LEE (Singapore)
 
8.15 am
Hightlights of Day 4 – Debate & Podium Sessions
LIM Kok Bin (Singapore)
 
8.30 am    Plenary 8
Chairpersons: Doddy SOEBADI (Indonesia); Sudhakar KRISHNAMURTI (India)

Challenges to Aging Men’s Health in Asia
Hui Meng TAN (Malaysia)
 
9.00 am    Plenary 9
Chairpersons: Akihiko OKUYAMA (Japan); Kok Bin LIM (Singapore)

Lifestyle Modification is an Important Therapeutic Approach for Sexual Disorders
Doddy SOEBADI (Indonesia)
 
9.30 am     Coffee Break
10.00 am Symposium 7: Metabolic Syndrome and Implications in Sexual Medicine
Chairpersons: Farid SAAD (Germany); Thomas I S HWANG (Taiwan)
Room 203
10.00 am
Testosterone Deficiency, Insulin Resistance and the Metabolic Syndrome
Michael Zitzmann (Germany)
 
10.20 am
Metabolic Syndrome in Women
Narayana REDDY (India)
 
10.40 am
Common Link Between Endothelial and Erectile Dysfunctions in Diabetes
Jintetsu SOH (Japan)
 
11.10 am
Impact of Metabolic Syndrome on Pharmacological Treatment of ED
Tai Young AHN (Korea)
 
11.30 am
ED as a Lifestyle Disorder
Sudhakar KRISHNAMURTI (India)
 
11.30 am   Symposium 8: New Insights into LUTS, BPH and Sexual Dysfunctions
Chairpersons: Osamu YOKOYAMA (Japan); Chin Tiong HENG (Singapore)
Room 203
11.30 am
Clinical Guidelines for BPH and ED
Yasusuke KIMOTO (Japan)
 
11.50 am
Chronic Pelvic Pain Syndrome and Sexual Dysfunction
Chia-Chu LIU (Taiwan)
 
12.10 pm
Pathophysiology of OAB and Male Sexual Dysfunction
Yoshiji MIWA (Japan)
 
12.30 pm
Neuroimaging Study of Human Brain for Research on ED and LUTS
Yasushi MIYAGAWA (Japan)
 
12.50 pm
Sexual Dysfunction in Chronic Renal Failure
Katsuyuki KURATSUKURI (Japan)
 
1.00 pm    Close 
Posters

P1
Female Sexual Dysfunction Related Questionnaires - A Literature Survey
CC LU; TC CHENG (Taiwan)

P2
Influences of Chronic Indirect Cigarette Smoking on Genital Sexual Arousal in Rat Model
Z LI; SO KIM; HS LEE; M LEE; K AHN; K PARK (Korea)

P3
Primary Care Doctors’ Decision Making in Discussing Sexual Health with Men
SF TONG; WY LOW; SB ISMAIL; S WILLCOCK; L TREVENA (Malaysia)

P4
How do Iranian Young People Perceive Sexual Matters? Expertise Perspectives
ZF KHALAF (Malaysia); WY LOW (Malaysia); EM KHOEI (Iran); B GHORBANI (Iran)

P5
The Prevalence and Severity of Self Reported ED and the Changes with Advancing Age in Men from Different Asia-Pacific Regions
G LEE (Malaysia)

P6
Couple Satisfaction to the Treatment of Erectile Dysfunction with Phosphodiesterase-5 Inhibitors
BP JIANN; ST HUANG (Taiwan)

P7
Effects of Chronic Oral Consumption of Sildenafil Citrate on Hormonal Levels and Testicular Function in Adult Male Rat
SM HOSSEINIPANAH; SH MOSAVIBAHAR; A BIDABADI (Iran)

P8
Health Care Utilization in Men with Erectile Dysfunction: Results of the Subang Aging Male (SAM) Study 
EM KHOO; SF TONG; WY LOW; BC LEE; VKM LEE; CJ NG; Z ZULKIFLI; HM TAN
(Malaysia)

P9
The Health Seeking Behaviour of Men with Erectile Dysfunction: Results of the Subang Aging Male (SAM) Study
SF TONG; EM KHOO; WY LOW; BC LEE; VKM LEE; CJ NG; Z ZUKIFLI; HM TAN (Malaysia)

P10
Utility of Hormonal Screening in Men with Erectile Dysfunction
JK TEO; KK NG; FC NG (Singapore)

P11
Relationship between Metabolic Syndrome and Erectile Dysfunction
K YAMAMOTO; H SASAKI; T ASO; K AOKI; M OTA (Japan)

P12
Association between Erectile Dysfunction, Hypogonadism and Metabolic Syndrome: Results from the Subang Men’s Health Study
WS TAN (UK); WY LOW (Malaysia); EM KHOO (Malaysia); HM TAN (Malaysia)

P13
Pharmacokinetics of the Single Administration of Udenafil and Tadalafil in the Patients with Benign Hyperplasia Prostate
MK KIM; JK Park (Korea
)

P14
Experience with Intra-Cavernous Injection in the Treatment of Erectile Dysfunction After Radical Prostatectomy: Dose Consideration
FP CHUANG (Taiwan); GH Sun (Taiwan); DL CHA (Taiwan); ST WU (Taiwan); AC NOVICK (USA); MM LAKIN (USA)

P15
Association between Sex Hormones and Metabolic Syndrome in Taiwan
CH LIAO; HS CHIANG; HJ YU
(Taiwan)
P16
Men with Primary Hypogonadism are at Risk of Sexual Dysfunction and should be accordingly Counseled
SH TEOH (Singapore); SA TEOH (UK); EJ TEOH (UK)
P17
Aging Males' Symptoms in Relation to the Genetically Determined Androgen Receptor CAG Polymorphism, Sex Hormone Levels and Sample Membership
M ZITZMANN; K NIENHAUS; J GROMOLL; G HEUFT; E NIESCHLAG; G SCHNEIDER (Germany)
P18
Depressive Symptoms in Ageing Men and their Relation to the Androgen Receptor Gene CAG Repeat Polymorphism and Testosterone Levels
M ZITZMANN; K NIENHAUS; J GROMOLL; G HEUFT; E NIESCHLAG; G SCHNEIDER (Germany)

P19
Analysis of the Relationship between Sexual Function and Hormone Value in the Klinefelter Syndrome Patients
K SHIGEHARA; E KOH; K SUGIMOTO; Y MAEDA; H KONAKA; A MIZOKAMI; M NAMIKI (Japan)

P20
Testosterone Administration Decreases Carotid Artery Intimal and Media Thickness as a Marker of Impaired Vascular Integrity in Middle-Aged Overweight Men
M ZITZMANN; E VORONA; M WENK; F SAAD; E NIESCHLAG (Germany)

P21
Comparison of the Prostate Cancer Practice Guidelines and Consensus among China, Singapore and Taiwan
CC LU; TC CHENG (Taiwan)

P22
Penile Curvature Salvage Correction Surgery
CH HSIEH ; HS CHEN ; WY LEE ; KL CHEN ; CH CHANG ; GL HSU (Taiwan)

P23
Impact of Penile Length Perception on the Self-esteem of Young Men - Penile Size Survey in Taiwan
FP CHUANG; ST WU; E MENG; SH TANG; GH SUN; T CHA (Taiwan)